August 29, 2024Open Access

In Vivo Efficacy of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in a Neutropenic Mouse Bloodstream Infection Model

DBDávid BalázsiUniversity of Debrecen ZTZoltán TóthUniversity of Debrecen JLJeffrey B. LockeScripps Institution of Oceanography

Key Points

Key points are not available for this paper at this time.

Abstract

Rezafungin is the first new drug approved to treat candidaemia and invasive candidiasis in more than 10 years. However, data are scant on the in vivo efficacy of rezafungin and the other three approved echinocandins against different

KI fragen

Bookmark

View Full Paper

KI fragen

Bookmark

View Full Paper

Cite This Study

Balázsi et al. (Thu,) studied this question.

synapsesocial.com/papers/68e5a5efb6db6435875401ec https://doi.org/https://doi.org/10.3390/jof10090617

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

2007 · 634 citations